MedTrace Logo

Optimized Cardioprotection Therapy in Obese Subjects With AMI

NCT04570514 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-09-30

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and mechanism of Adipokines Cardiac Protection in Obese Patients With acute myocardial infarction (AMI) Who Have Undergone Percutaneous Coronary Intervention (PCI).

Conditions

  • Acute Myocardial Infarction
  • Myocardial Reperfusion Injury
  • Obesity
  • Adiposis; Heart

Interventions

PROCEDURE

PCI

percutaneous coronary intervention (PCI)

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Dongdong Sun, M.D.,Ph.D · Xijing Hospital

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2020-10-01
Completion
2020-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04570514 on ClinicalTrials.gov